Literature DB >> 28096260

FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.

Desiree Wanders1, Laura A Forney2, Kirsten P Stone2, David H Burk3, Alicia Pierse2, Thomas W Gettys4.   

Abstract

Dietary methionine restriction (MR) produces a rapid and persistent remodeling of white adipose tissue (WAT), an increase in energy expenditure (EE), and enhancement of insulin sensitivity. Recent work established that hepatic expression of FGF21 is robustly increased by MR. Fgf21-/- mice were used to test whether FGF21 is an essential mediator of the physiological effects of dietary MR. The MR-induced increase in energy intake and EE and activation of thermogenesis in WAT and brown adipose tissue were lost in Fgf21-/- mice. However, dietary MR produced a comparable reduction in body weight and adiposity in both genotypes because of a negative effect of MR on energy intake in Fgf21-/- mice. Despite the similar loss in weight, dietary MR produced a more significant increase in in vivo insulin sensitivity in wild-type than in Fgf21-/- mice, particularly in heart and inguinal WAT. In contrast, the ability of MR to regulate lipogenic and integrated stress response genes in liver was not compromised in Fgf21-/- mice. Collectively, these findings illustrate that FGF21 is a critical mediator of the effects of dietary MR on EE, remodeling of WAT, and increased insulin sensitivity but not of its effects on hepatic gene expression.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28096260      PMCID: PMC5360300          DOI: 10.2337/db16-1212

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  57 in total

1.  ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene.

Authors:  Fai Siu; Perry J Bain; Rene LeBlanc-Chaffin; Hong Chen; Michael S Kilberg
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

2.  Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1.

Authors:  Ricardo J Samms; Dennis P Smith; Christine C Cheng; Patrick P Antonellis; James W Perfield; Alexei Kharitonenkov; Ruth E Gimeno; Andrew C Adams
Journal:  Cell Rep       Date:  2015-05-05       Impact factor: 9.423

3.  Brown adipose tissue activity controls triglyceride clearance.

Authors:  Alexander Bartelt; Oliver T Bruns; Rudolph Reimer; Heinz Hohenberg; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Horst Weller; Christian Waurisch; Alexander Eychmüller; Philip L S M Gordts; Franz Rinninger; Karoline Bruegelmann; Barbara Freund; Peter Nielsen; Martin Merkel; Joerg Heeren
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

4.  Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.

Authors:  Murielle M Véniant; Glenn Sivits; Joan Helmering; Renee Komorowski; Jae Lee; Wei Fan; Carolyn Moyer; David J Lloyd
Journal:  Cell Metab       Date:  2015-05-05       Impact factor: 27.287

5.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.

Authors:  Jing Xu; Shanaka Stanislaus; Narumol Chinookoswong; Yvonne Y Lau; Todd Hager; Jennifer Patel; Hongfei Ge; Jen Weiszmann; Shu-Chen Lu; Melissa Graham; Jim Busby; Randy Hecht; Yue-Sheng Li; Yang Li; Richard Lindberg; Murielle M Véniant
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

6.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.

Authors:  William L Holland; Andrew C Adams; Joseph T Brozinick; Hai H Bui; Yukiko Miyauchi; Christine M Kusminski; Steven M Bauer; Mark Wade; Esha Singhal; Christine C Cheng; Katherine Volk; Ming-Shang Kuo; Ruth Gordillo; Alexei Kharitonenkov; Philipp E Scherer
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

7.  Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue.

Authors:  Ying Cheng; Qingshu Meng; Chunxia Wang; Houkai Li; Zhiying Huang; Shanghai Chen; Fei Xiao; Feifan Guo
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

8.  FGF21 regulates metabolism and circadian behavior by acting on the nervous system.

Authors:  Angie L Bookout; Marleen H M de Groot; Bryn M Owen; Syann Lee; Laurent Gautron; Heather L Lawrence; Xunshan Ding; Joel K Elmquist; Joseph S Takahashi; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

9.  Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas.

Authors:  Garima Singhal; Ffolliott Martin Fisher; Melissa J Chee; Tze Guan Tan; Abdelfattah El Ouaamari; Andrew C Adams; Robert Najarian; Rohit N Kulkarni; Christophe Benoist; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.

Authors:  Xunshan Ding; Jamie Boney-Montoya; Bryn M Owen; Angie L Bookout; Katie Colbert Coate; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

View more
  48 in total

1.  Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice.

Authors:  Karlton R Larson; Aki T-B Chaffin; Michael L Goodson; Yanbin Fang; Karen K Ryan
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

2.  Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms.

Authors:  Deyang Yu; Shany E Yang; Blake R Miller; Jaclyn A Wisinski; Dawn S Sherman; Jacqueline A Brinkman; Jay L Tomasiewicz; Nicole E Cummings; Michelle E Kimple; Vincent L Cryns; Dudley W Lamming
Journal:  FASEB J       Date:  2018-01-30       Impact factor: 5.191

Review 3.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

Review 4.  Sensing and signaling mechanisms linking dietary methionine restriction to the behavioral and physiological components of the response.

Authors:  Laura A Forney; Kirsten P Stone; Desiree Wanders; Thomas W Gettys
Journal:  Front Neuroendocrinol       Date:  2017-12-21       Impact factor: 8.606

5.  Sexually Dimorphic Effects of Dietary Methionine Restriction are Dependent on Age when the Diet is Introduced.

Authors:  Laura A Forney; Kirsten P Stone; Amanda N Gibson; Alicia M Vick; Landon C Sims; Han Fang; Thomas W Gettys
Journal:  Obesity (Silver Spring)       Date:  2020-02-03       Impact factor: 5.002

6.  Dietary Methionine Restriction Reduces Inflammation Independent of FGF21 Action.

Authors:  Shaligram Sharma; Taylor Dixon; Sean Jung; Emily C Graff; Laura A Forney; Thomas W Gettys; Desiree Wanders
Journal:  Obesity (Silver Spring)       Date:  2019-06-17       Impact factor: 5.002

7.  Weight Loss and Concomitant Adipose Autophagy in Methionine-Restricted Obese Mice is Not Dependent on Adiponectin or FGF21.

Authors:  Diana Cooke; Dwight Mattocks; Sailendra N Nichenametla; Rea P Anunciado-Koza; Robert A Koza; Gene P Ables
Journal:  Obesity (Silver Spring)       Date:  2020-04-29       Impact factor: 5.002

8.  Restoration of metabolic health by decreased consumption of branched-chain amino acids.

Authors:  Nicole E Cummings; Elizabeth M Williams; Ildiko Kasza; Elizabeth N Konon; Michael D Schaid; Brian A Schmidt; Chetan Poudel; Dawn S Sherman; Deyang Yu; Sebastian I Arriola Apelo; Sara E Cottrell; Gabriella Geiger; Macy E Barnes; Jaclyn A Wisinski; Rachel J Fenske; Kristina A Matkowskyj; Michelle E Kimple; Caroline M Alexander; Matthew J Merrins; Dudley W Lamming
Journal:  J Physiol       Date:  2017-12-27       Impact factor: 5.182

9.  Dietary Methionine Restriction Signals to the Brain Through Fibroblast Growth Factor 21 to Regulate Energy Balance and Remodeling of Adipose Tissue.

Authors:  Laura A Forney; Han Fang; Landon C Sims; Kirsten P Stone; Leighann Y Vincik; Alicia M Vick; Amanda N Gibson; David H Burk; Thomas W Gettys
Journal:  Obesity (Silver Spring)       Date:  2020-10       Impact factor: 5.002

10.  Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes.

Authors:  Zhaoxia Liang; Leishen Wang; Huikun Liu; Yuhang Chen; Tao Zhou; Yoriko Heianza; Junhong Leng; Weiqin Li; Xilin Yang; Yun Shen; Ru Gao; Gang Hu; Lu Qi
Journal:  Clin Nutr       Date:  2019-09-10       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.